Discover 1,170 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,170
Featured
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer
Location: Montreal, Boston MA, New Haven CT, Toronto, London,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06820463
Phase2, Recruiting
Featured
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Montreal, Lebanon NH, Utica NY, North Worcester MA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819891
Phase3, Recruiting
Featured
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
for
Non-Segmental Vitiligo (NSV), Alopecia Areata,
Location: Pointe-Claire, Markham, Barrie, Richmond Hill,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07136467
Recruiting
Featured
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Suicide Prevention, Suicide, Suicide and Self-harm, Depression,
Location: Montreal, Sherbrooke, Quebec City, Fredericton,
Sponsor: Unity Health Toronto
Sex: All
Age: 18+
Code: NCT06571916
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
for
Parkinson Disease
Location: Montreal, Ottawa, Boston MA, Rochester NY, New Haven CT,
Sponsor: Michael J. Fox Foundation for Parkinson's Research
Sex: All
Age: 30+
Code: NCT04477785
Recruiting
Active & Responsive
The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes
for
Insulin Dependent Diabetes Mellitus,
Location: Montreal
Sponsor: McGill University
Sex: All
Age: 12+
Code: NCT07348432
Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for
HIV Infections
Location: Montreal, Syracuse NY, New Haven CT, Toronto,
Sponsor: ViiV Healthcare
Sex: All
Age: 12+
Code: NCT07650916
Phase3, Recruiting
Active & Responsive
SYNERGIC-2 Trial (SYNchronizing, Exercises and Remedies to GaIn Cognition@home)
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
for
Plaque Psoriasis
Location: Montreal, Quebec, Peterborough, Boston MA, Cromwell CT,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07449702
Phase2, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Montreal, Terrebonne, Rochester NY, New Haven CT,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18 - 55
Code: NCT05854667
Phase2, Recruiting
Active & Responsive
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
for
Primary Biliary Cholangitis
Location: Montreal, Ottawa, Boston MA, New Haven CT, Manhasset NY,
Sponsor: Ipsen
Sex: All
Age: 0+
Code: NCT06447168
Recruiting
Active & Responsive
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
for
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy),
Location: Montreal, Stony Brook NY, New York NY, Baltimore MD,